First of all, a quick reminder of the basics, because you do not need to be a CLO specialist to follow the analysis.
A leveraged loan is a senior secured loan to a company in the high-yield universe. It normally pays a floating interest rate. A CLO buys a large portfolio of these loans, typically 150 to 250, and finances the portfolio by issuing several layers of debt with different levels of risk and return.
The CLO manager can generally reinvest principal for four to five years. During that period, the quality of the underlying loans can change materially, even if the CLO itself continues to carry the same ratings.
When I look at a CLO, I am essentially trying to answer five questions.
First, is the structure still providing enough protection? I look at the cushion above the overcollateralization triggers and how quickly it is changing.
Second, is the loan portfolio deteriorating? The percentage of loans rated CCC or below is one of the first places I look.
Third, is the portfolio generating enough cash? Interest coverage can tell us whether there is enough interest income to support the CLO’s payment obligations, but the quality of that income also matters.
Fourth, what is the manager doing about weaker loans? Trading activity can tell us whether the manager is actively managing deterioration or allowing weaker credits to remain in the portfolio.
Fifth, how should an allocator get exposure? The choice is not necessarily between one CLO and another. It may be between owning a few CLOs directly and investing through a CLO fund.
You do not need a full CLO model to answer these questions initially. The trustee report usually gives you enough information to identify whether the structure, the collateral or the cash generation is beginning to deteriorate, and whether a deeper analysis is warranted.
1. Do I need a full CLO model to know if something is wrong?
No. A full CLO model recreates the entire transaction, including the loan portfolio, the different debt tranches and the rules governing how cash moves between them. It is useful for testing what happens under different default and recovery scenarios. But you can identify early signs of deterioration from the trustee report without rebuilding all of this.
I start with the trustee report and look at five things: the outstanding tranche balances, the overcollateralization tests, the interest coverage tests, the size and direction of the lowest-rated loan bucket, and the manager’s trading activity during the period.
The change over time is often more informative than the level itself.
Suppose the senior overcollateralization cushion is eight percentage points above its trigger and falls to six, then four, over two reporting periods. The transaction has not necessarily breached a test. But the protection available to the senior tranche is clearly declining.
By contrast, a cushion that stays around five points for several quarters tells me something different. The level may not be generous, but the structure is stable.
My rule is simple. One weak number can be noise. Two numbers deteriorating together deserve investigation. Three consecutive periods of deterioration usually justify a much deeper review.
The trustee report is therefore a triage tool. It tells me whether I need the full model, not whether I need it before I can form a view.
2. What does the overcollateralization cushion actually tell me?
Overcollateralization is one of the main protections built into a CLO.
In simple terms, it compares the value of the loan collateral with the debt that the CLO has issued. If the collateral loses value through defaults, losses, or other adjustments, the ratio falls.
Each tranche has a relevant test level. The difference between the actual ratio and that level is the cushion.
For example, if the relevant test level is 120 percent and the current ratio is 125 percent, there are five percentage points of protection above the trigger. If the ratio falls to 122 percent, only two points remain.
Why does is this important?
If a test is breached, the cash waterfall can change. Cash that would normally have flowed to junior investors can instead be redirected to repay more senior debt.
That protects senior investors, but it can materially reduce cash flows to mezzanine and equity investors.
So I do not look at the ratio in isolation. I look at the distance to the trigger and the speed at which that distance is changing.
A stable five-point cushion can be manageable. A cushion falling from eight points to four points in two reporting periods deserves much more attention.
The next question is what caused the decline. Defaults are an obvious possibility. But downgrades, loans sold below par and other changes in the collateral can also reduce the protection.
3. What does a 7% CCC bucket really mean?
The 7% figure refers to the share of the CLO's collateral pool that can be rated CCC+ or below before the structure starts applying a penalty in its overcollateralization tests. It is not a 7% default rate, and it does not mean that 7% of the loans have already defaulted.It means the quality of the collateral has deteriorated enough that the structure may start to feel the effect. Loans rated CCC are generally the weakest part of the performing collateral pool. They have a much higher probability of default than higher-rated loans.
The precise treatment of these loans is transaction-specific. In many CLOs, there is a threshold above which excess CCC exposure receives less than full credit in certain collateral tests. That means an increase in CCC exposure can affect the reported protection even before a loan actually defaults.
Consider a simple example. If the CCC bucket rises from 4% to 6%, the portfolio is clearly weaker, but the structural impact may still be limited. If it rises from 4% to 8% in one quarter, I want to know why. Was the increase caused by a broad deterioration across the portfolio? Did several loans get downgraded at the same time? Is the exposure concentrated in one sector?
I also look at what the manager did. If the manager sold a deteriorating loan at 98 before it was downgraded, that may indicate good trading discipline and an effort to limit downside risk. If the manager retained the loan and it subsequently moved into CCC, it may indicate that the manager was slower to react to the deterioration. The same increase in the CCC bucket therefore does not necessarily tell the same story about the manager's credit selection and risk management.
4. How do I read interest coverage without building a model?
Interest coverage asks a simple question: does the loan portfolio generate enough interest income to meet the payments required by the CLO structure? The reported ratio can therefore look healthy while the underlying cash generation is becoming less comfortable.
I start with the reported interest coverage cushion and then ask three questions.
First, how much of the reported income is actually cash interest? Some loans can pay part of their interest in kind. That increases reported interest income without producing the same amount of cash.
Second, how durable is the spread income? A CLO may currently own loans with attractive spreads, but those loans can refinance at tighter spreads. The income available to the structure can then decline.
Third, has the manager introduced fixed-rate assets into a predominantly floating-rate liability structure, and if so, is the interest-rate risk properly hedged?
This is why I distinguish between reported coverage and cash-pay coverage. If reported interest coverage looks comfortable but the amount of cash interest available to the structure is much lower, I would treat the reported cushion as less robust.
That does not mean the CLO is about to fail. It means there is less cash available to absorb deterioration in the loan portfolio.
5. Should I buy individual CLOs or a CLO fund?
For a wealth manager or family office, this may be the most important question of all. The choice is not simply between two ways of getting CLO exposure. It is a choice between control and diversification, but also between doing the credit work yourself and delegating it to a fund manager.
Buying individual CLO tranches gives you much more control. You can choose the manager, transaction, tranche, maturity and price. You can also decide how much credit risk and structural protection you are willing to accept. But that control comes with a cost: you have to analyze each transaction yourself, monitor it over time and accept the concentration that comes with owning a relatively small number of positions.
A CLO fund solves part of that problem. It can diversify across dozens or even hundreds of CLOs, managers, sectors and tranches, while allowing investors to enter with a much smaller ticket. The trade-off is that you give up some control and pay another layer of fees.
The fund can therefore be the better vehicle without necessarily being the better investment. The important question is what you are actually getting for the additional fee and delegation.
I would focus on four questions.
First, how diversified is the portfolio?
Do not stop at the number of CLOs in the portfolio. Look at how much exposure the fund has to its largest managers, individual transactions and underlying sectors. A fund holding 50 CLOs may still have significant concentration if several positions are managed by the same large managers or have similar exposure to the same industries.
Diversification should reduce the impact of an individual credit problem. If a single manager, transaction or sector can materially affect the fund’s performance, the apparent diversification may be less useful than it looks.
Second, what are you actually buying?
The headline rating of the fund tells you very little about the risks inside the portfolio. You need to understand which CLO tranches the fund owns and where they sit in the capital structure.
A fund concentrated in AAA and AA CLO tranches has a very different risk profile from one investing in BBB or BB tranches, even if both funds have attractive headline yields. I would also look at the underlying CLOs’ overcollateralization cushions, CCC exposure, portfolio quality and remaining reinvestment period.
Third, where is the return coming from?
A high distribution yield does not automatically mean that the underlying credit is attractive. I would want to separate the return generated by the underlying CLO tranches from the effects of leverage, fund fees, trading gains and changes in market prices. A fund can produce a strong recent return because it benefited from falling spreads or successful trading, rather than because the underlying credit risk is particularly well compensated.
Fourth, how much can I actually see?
This is particularly important for a private wealth investor. A fund may provide diversification, but you are relying on the manager to select and monitor the underlying CLOs. How frequently does the fund disclose its holdings? Can you see the individual CLO managers and tranches? Does it report changes in CCC exposure, overcollateralization cushions and deteriorating positions? Does it explain why it sold a position or increased exposure to a particular manager?
The more limited the transparency, the more difficult it becomes to determine whether the fund is actually doing something you could not replicate yourself.
This is where independent credit analysis can add value. The question is not simply whether the fund manager has produced a good track record. It is whether the portfolio is taking risks that you understand, whether you are being adequately compensated for those risks, and whether the additional fees paid to the fund manager are justified by the diversification and credit selection you receive in return.
For an investor with the expertise and resources to analyze CLOs directly, individual tranches may offer greater control and potentially better value. For an investor who cannot realistically monitor a large CLO portfolio, a fund may be the more practical solution.
When should I ask for a second opinion?
There are three situations when I think an independent review can be particularly useful. The first is before adding to a CLO position that you already own. The question is not simply whether the tranche remains investment grade and offers an attractive spread. You want to know whether the protection supporting that rating is improving or deteriorating.
The second is when a tranche goes on negative watch or receives a downgrade. The rating action is important, but the next question is why it happened and whether the underlying collateral is still deteriorating.
The third is when two or more indicators move in the wrong direction together.
For example, suppose the CCC bucket increases sharply while the overcollateralization cushion falls. Those two numbers are not independent. The same deterioration in the loan portfolio can affect both collateral quality and structural protection.
That is when I want to understand what is happening at loan level.
My output in this situation would not normally be a 50-page model. It would be much shorter: where the transaction stands today, which indicators have changed, what would have to happen for a structural test to become a problem, and whether the current price compensates you for that risk.
If the answer is unclear, that is when I would go deeper into the trustee report, offering circular and historical payment dates.
Most of the time, public information is enough to determine whether deeper work is justified.
What would change my view?
The risk I would watch most closely is a broadening of loan deterioration.
If downgrades remain concentrated in weaker sectors, the problem may remain manageable at individual transaction level. If deterioration spreads into more defensive sectors, falling cushions could become a much broader structural issue.
I would also watch how managers deal with weak credits. If loans are repeatedly amended, extended or otherwise kept alive without a corresponding improvement in fundamentals, the reported CCC bucket may look relatively stable while other measures of credit quality deteriorate.
That is why I do not treat any single trustee-report metric as decisive.
The value is in connecting the numbers.
My previous article explained where to look. This one is about how to interpret what you find, and how that analysis can inform the actual investment decision.
Whether you choose individual CLOs or a CLO fund, the underlying question is the same: are you being paid adequately for the credit and structural risk you are taking?
That is also where I think independent credit research can be useful. Not as a substitute for the manager, but as a way of challenging the assumptions behind the investment.
If you own a CLO fund and there is one position you keep coming back to, send me the name and what concerns you about it. I read every reply.
Alessandro Rovelli
Rovelli Research
Independent credit investment research
